medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2014, Number 3

<< Back Next >>

Ann Hepatol 2014; 13 (3)

An update on management of Budd-Chiari syndrome

Mancuso A

Language: English
References: 29
Page: 323-326
PDF size: 66.97 Kb.


ABSTRACT

The topic of this paper is to report an update on management of Budd-Chiari syndrome (BCS). Actually, the flow-chart of BCS management comes from experts opinion and is not evidence-based due to the rarity of BCS. Management of BCS follows a step-wise strategy. Anticoagulation and medical therapy should be the first line treatment. Revascularization or TIPS in case of no response to medical therapy. OLT as a rescue therapy. Surgery has limited but important space, especially in cases with high inferior vena cava obstruction not suitable for endovascular treatment. However, no clear indication can actually be given about the timing of different treatments. Moreover, there is some concern about treatment of some subgroup of patients, especially regarding the risk of recurrence after liver transplantation. This paper propose a new algorithm of BCS management suggesting an earlier therapeutic approach when clinical signs are evident.


REFERENCES

  1. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009; 49: 1729-64.

  2. Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, Condat B, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006; 44: 1308-16.

  3. Mancuso A. Budd-Chiari syndrome management: lights and shadows. World J Hepatol 2011; 3: 262-4.

  4. Bilbao JI, Pueyo JC, Longo JM, Arias M, Herrero JI, Benito A, Barettino MD, et al. Interventional therapeutic techniques in Budd-Chiari syndrome. Cardiovasc Intervent Radiol 1997; 20: 112-19.

  5. Fisher NC, McCafferty I, Dolapci M, Wali M, Buckels JA, Olliff SP, Elias E. Managing Budd-Chiari syndrome: a retros-pective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 1999; 44: 568-74.

  6. Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 2006; 55: 878-84.

  7. Perelló A, García-Pagán JC, Gilabert R, Suárez Y, Moitinho E, Cervantes F, Reverter JC, et al. TIPS is a useful longterm derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002; 35: 132-9.

  8. Mancuso A, Fung K, Mela M, Tibballs J, Watkinson A, Burroughs AK, Patch D. TIPS for acute and chronic Budd- Chiari syndrome: a single-centre experience. J Hepatol 2003; 38: 751-4.

  9. Rössle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004; 135: 394-403.

  10. Mancuso A, Watkinson A, Tibballs J, Patch D, Burroughs AK. Budd-Chiari syndrome with portal, splenic, and superior mesenteric vein thrombosis treated with TIPS: who dares wins. Gut 2003; 52: 438.

  11. Darwish MS, Valla DC, De Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, Janssen HL. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 2006; 101: 83-90.

  12. Garcia-Pagán JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, Vizzini G, et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008; 135: 808-15.

  13. Ringe B, Lang H, Oldhafer KJ, Gebel M, Flemming P, Georgii A, Borst HG, et al. Which is the best surgery for Budd- Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology 1995; 21: 1337-44.

  14. Hemming AW, Langer B, Greig P, Taylor BR, Adams R, Heathcote EJ. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg 1996; 171: 176-180; discussion 180-181.

  15. Orloff MJ, Isenberg JI, Wheeler HO, Daily PO, Girard B. Budd-Chiari syndrome revisited: 38 years’ experience with surgical portal decompression. J Gastrointest Surg 2012; 16: 286-300; discussion 300.

  16. Zhang Y, Zhao H, Yan D, Xue H, Lau WY. Superior mesenteric vein-caval-right atrium Y shunt for treatment of Budd-Chiari syndrome with obstruction to the inferior vena cava and the hepatic veins-a study of 62 patients. J Surg Res 2011; 169: e93-e99.

  17. Srinivas BC, Dattatreya PV, Srinivasa KH, Prabhavathi CN. Inferior vena cava obstruction: long-term results of endovascular management. Indian Heart J 2012; 64: 162-9.

  18. Mancuso A, Martinelli L, De Carlis L, Rampoldi AG, Magenta G, Cannata A, Belli LS. A caval homograft for Budd-Chiari syndrome due to inferior vena cava obstruction. World J Hepatol 2013; 27: 292-5.

  19. Halff G, Todo S, Tzakis AG, Gordon RD, Starzl TE. Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990; 211: 43-9.

  20. Rao AR, Chui AK, Gurkhan A, Shi LW, Al-Harbi I, Waugh R, Verran DJ, et al. Orthotopic liver transplantation for treatment of patients with Budd-Chiari syndrome: a Singecenter experience. Transplant Proc 2000; 32: 2206-207.

  21. Ulrich F, Steinmüller T, Lang M, Settmacher U, Müller AR, Jonas S, Tullius SG, et al. Liver transplantation in patients with advanced Budd-Chiari syndrome. Transplant Proc 2002; 34: 2278.

  22. Srinivasan P, Rela M, Prachalias A, Muiesan P, Portmann B, Mufti GJ, Pagliuca A, et al. Liver transplantation for Budd- Chiari syndrome. Transplantation 2002; 73: 973-7.

  23. Mentha G, Giostra E, Majno PE, Bechstein WO, Neuhaus P, O’Grady J, Praseedom RK, et al. Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol 2006; 44: 520-8.

  24. Segev DL, Nguyen GC, Locke JE, Simpkins CE, Montgomery RA, Maley WR, Thuluvath PJ. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl 2007; 13: 1285-94.

  25. Choi GS, Park JB, Jung GO, Chun JM, Kim JM, Moon JI, Kwon CH, et al. Living donor liver transplantation in Budd- Chiari syndrome: a single-center experience. Transplant Proc 2010; 42: 839-42.

  26. Kiladjian JJ, Cervantes F, Leebeek FW, Marzac C, Cassinat B, Chevret S, Cazals-Hatem D, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood 2008; 111: 4922-9.

  27. Darwish MS, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009; 151: 167-75.

  28. Seijo S, Plessier A, Hoekstra J, Dell’Era A, Mandair D, Rifai K, Trebicka J, et al. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology 2013; 57: 1962-8.

  29. Mancuso A. Budd-Chiari Syndrome Management: Timing of Treatment Is an Open Issue. Hepatology (IN PRESS).




2020     |     www.medigraphic.com